DS5 Isolated Bipolar Constant Current Stimulator DS5 Operator's Manual 5.0
Bibliography
1. Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in amyotrophic lateral
sclerosis. Brain. 1995;118 ( Pt 1):217-25.
2. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral
nerve. Muscle & Nerve 1998; 21: 137-158.
3. Kaji R, Bostock H, Kohara N, Murase N, Kimura J, Shibasaki H. Activity-dependent conduction block
in multifocal motor neuropathy. Brain. 2000;123 ( Pt 8):1602-11.
4. Kiernan MC, Isbister GK, Lin CS, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after
ingestion of puffer fish. Ann Neurol. 2005;57(3):339-48.
5. Kiernan MC, Walters RJ, Andersen KV, Taube D, Murray NM, Bostock H. Nerve excitability changes in
chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain. 2002;125(Pt
6):1366-78.
6. Kiernan MC, Guglielmi JM, Kaji R, Murray NM, Bostock H. Evidence for axonal membrane
hyperpolarization in multifocal motor neuropathy with conduction block. Brain. 2002;125(Pt 3):664-
75.
7. Kiernan MC, Lin CS, Andersen KV, Murray NM, Bostock H. Clinical evaluation of excitability measures
in sensory nerve. Muscle Nerve. 2001;24(7):883-92.
8. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous
motor unit activity. J Neurol Neurosurg Psychiatry. 2001;70(1):56-64.
9. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability
properties of human motor axons. Brain. 2000;123 Pt 12:2542-51.
10. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new
approach in clinical testing. Muscle Nerve. 2000;23(3):399-409.
11. Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Altered motor nerve
excitability in end-stage kidney disease. Brain. 2005;128(Pt 9):2164-74. Epub 2005 Jun 9.
12. Kuwabara S, Bostock H, Ogawara K, Sung JY, Kanai K, Mori M, Hattori T, Burke D. The refractory
period of transmission is impaired in axonal Guillain-Barre syndrome. Muscle Nerve. 2003;28(6):683-
9.
13. Kuwabara S, Ogawara K, Sung JY, Mori M, Kanai K, Hattori T, Yuki N, Lin CS, Burke D, Bostock H.
Differences in membrane properties of axonal and demyelinating Guillain-Barre syndromes. Ann
Neurol. 2002;52(2):180-7.
14. Kuwabara S, Kanai K, Sung JY, Ogawara K, Hattori T, Burke D, Bostock H. Axonal hyperpolarization
associated with acute hypokalemia: multiple excitability measurements as indicators of the
membrane potential of human axons. Muscle Nerve. 2002;26(2):283-7.
15. Lin CS, Chan JH, Pierrot-Deseilligny E, Burke D. Excitability of human muscle afferents studied using
threshold tracking of the H reflex. J Physiol 2002; 545: 661-669.
16. Nodera H, Bostock H, Kuwabara S, Sakamoto T, Asanuma K, Jia-Ying S, Ogawara K, Hattori N,
Hirayama M, Sobue G, Kaji R. Nerve excitability properties in Charcot-Marie-Tooth disease type 1A.
Brain. 2004;127(Pt 1):203-11. Epub 2003 Nov 7.
17. Sung JY, Kuwabara S, Kaji R, Ogawara K, Mori M, Kanai K, Nodera H, Hattori T, Bostock H.
Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with
clinical profiles. Muscle Nerve. 2004;29(1):28-37.
18. Tan SV, Lee PJ, Walters RJ, Mehta A, Bostock H. Evidence for motor axon depolarization in Fabry
disease. Muscle Nerve. 2005;32(4):548-51.
Digitimer Ltd. 34 of 52 Copyright © 2009
To Next Page
Loading...